Page last updated: 2024-09-04

moxifloxacin and metronidazole

moxifloxacin has been researched along with metronidazole in 105 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (metronidazole)	Trials (metronidazole)	Recent Studies (post-2010) (metronidazole)
3,157	552	1,690	13,983	2,489	3,725

Research

Studies (105)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (0.95)	18.2507
2000's	33 (31.43)	29.6817
2010's	58 (55.24)	24.3611
2020's	13 (12.38)	2.80

Authors

Authors	Studies
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S	1
Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA	1
Bryk, A; Kanervo-Nordström, A; Könönen, E; Niemi, P	1
Galang, MA; Gerding, DN; Hecht, DW; Johnson, S; Osmolski, JR; Sambol, SP	1
Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F	1
Bitting, C; Gruppo, V; Johnson, CM; Lenaerts, AJ; Marietta, KS; Orme, IM; Woolhiser, L	1
Lombardo, F; Obach, RS; Waters, NJ	1
Betriu, C; Culebras, E; Gómez, M; López, F; Picazo, JJ; Rodríguez-Avial, I	1
Hsueh, PR; Huang, YT; Liao, CH; Lin, HY; Liu, CY; Yen, LC	1
Karlowsky, JA; Laing, NM; Zhanel, GG	1
Jacobus, NV; McDermott, LA; Snydman, DR	2
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Chong, Y; Jeong, SH; Kim, MS; Lee, K; Lee, Y; Park, Y; Yong, D	1
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bonnet, M; Cooper, CB; Denny, WA; Franzblau, SG; Lee, HH; Thompson, AM; Wan, B; Wong, GS	1
Edlund, C; Nord, CE; Sabouri, S	1
Gottlieb, T; Leroi, MJ; Siarakas, S	1
Behra-Miellet, J; Dubreuil, L; Jumas-Bilak, E	1
Brooke, CJ; Hampson, DJ; Riley, TV	1
Eick, S; Pfister, W; Seltmann, T	1
Chuah, SK; Gollapudi, S; Thadepalli, H	1
Choudhri, S; Fogarty, CM; Hamed, K; Katz, E; Larsen, LS; Song, J	1
Eick, S; Pfister, W	1
Hermsen, ED; Hovde, LB; Rodvold, KA; Rotschafer, JC; Sprandel, KA	1
Almassi, GH; Brown, KR; Edmiston, CE; Kehl, KS; Krepel, CJ; Lewis, BD; Loehrl, TA; Seabrook, GR; Smith, TL; Somberg, LB; Towne, JB	1
Cheon, JH; Jung, HC; Kim, JM; Kim, JS; Kim, N; Lee, DH; Song, IS	1
Alefelder, M; Arvis, P; Cronjé, HS; Kureishi, A; Paszkowski, T; Rakoczi, I; Reimnitz, P; Ross, JD; Vildaite, D	1
Bélanger, M; LeCorn, DW; Progulske-Fox, A; Rojas, MF; Vertucci, FJ	1
Alvarez, M; Diz, P; Limeres, J; Potel, C; Tomás, I; Tomás, M; Velasco, D	1
Jung, HC; Kang, JM; Kim, JS; Kim, N; Kim, YR; Lee, DH; Park, YS; Song, IS	1
Bästlein, E; Haferland, C; Jebens, C; Kirsch, C; Knoth, H; Kuhlisch, E; Lehn, N; Madisch, A; Miehlke, S; Morgner, A; Schneider-Brachert, W; Stolte, M; Zekorn, C	1
Bago, J; Bago, P; Bakula, V; Marusić, M; Pevec, B; Tomić, M	1
Hampel, B; Lippert, H; Muehlhofer, E; Reimnitz, P; Weiss, G	1
Chen, MJ; Hampel, B; Ma, EL; Solomkin, J; Zhao, YP	1
Heystek, M; Ross, JD	1
Bin, M; Donghai, W; Kehu, Y; Lijuan, Y; Quanlin, G; Wenzhen, Y; Yumin, L	1
Boothby, M; Page, J; Pryor, R; Ross, JD	1
Fattorini, L; Filippini, P; Iona, E; Neyrolles, O; Peyron, P; Piccaro, G	1
Ardila, CM; Granada, MI; Guzmán, IC	1
Banaszkiewicz, A; Młynarczyk, G; Obuch-Woszczatyński, P; Pituch, H; Radzikowski, A; Wultańska, D	1
Hsueh, PR; Lee, PI; Yang, JC	1
Arvis, P; Hampel, B; Judlin, P; Liao, Q; Liu, Z; Reimnitz, P	1
Dörffel, Y; Loening-Baucke, V; Mendling, W; Schilling, J; Swidsinski, A	1
Behillil, S; Berche, P; Coignard, H; Consigny, PH; Fraitag, S; Guet-Revillet, H; Jais, JP; Join-Lambert, O; Jullien, V; Le Guern, AS; Leflèche, A; Lortholary, O; Nassif, A; Nassif, X; Poirée, S; Ribadeau-Dumas, F; Thèze, J	1
Hsueh, PR; Huang, YT; Ko, WC; Lee, NY; Lee, TF; Liao, CH; Lin, SY; Lin, YC; Tsai, PJ	1
Al-Nawas, B; d'Hoedt, B; Karbach, J; Mouratidou, A	1
Baik, GH; Jung, HC; Kim, GH; Kim, HB; Kim, JM; Kim, JY; Kim, NY; Kim, SJ; Lee, DH; Nam, RH; Song, IS	1
Farina, C; Russello, G; Russo, A; Scaltrito, MM; Sisto, F	1
Ark, C; Aşicioğlu, O; Ertas, IE; Gungorduk, K; Ozdemir, A; Sanci, M; Yildirim, G	1
Jo, HJ; Kim, MS; Kim, N; Kim, SE; Lee, DH; Park, YS; Shin, CM	1
Ang, TL; Song, M	1
Li, F; Liu, Y; Pu, C; Ren, X; Ren, Y; Sui, DJ; Sun, L; Sun, T; Wang, R; Yang, Z	1
Diao, C; Liang, L; Liu, X; Wang, L; Xu, Y; Zhang, J; Zhang, S	1
Akdoğan, RA; Bedir, R; Copur, A; Rakici, H; Yilmaz, A	1
Jo, HJ; Kim, N; Lee, DH; Lee, ST; Lim, JH; Park, YS; Shin, CM; Song, IS	1
Hegarty, JP; Jayarao, BM; Lumadue, J; Stewart, DB; Varshney, JB; Venkitanarayanan, K; Very, KJ; Williams, JL	1
Cho, Y; Chung, KH; Hwang, JH; Jeong, SH; Jin, E; Kim, JW; Kim, N; Lee, DH; Seo, JY; Shin, CM	1
Carter, GP; Elliott, B; Howden, BP; Jenkin, GA; Korman, TM; Kotsanas, D; Lyras, D; Mackin, KE; Riley, TV; Rood, JI	1
Hwang, JJ; Kim, N; Lee, AR; Lee, DH; Park, YS; Shin, CM; Yoon, H	1
Blee, K; Evans, C; Horner, P; Muir, P; O'Mahony, C; Radcliffe, K	1
Gurgan, CA; Guzeldemir-Akcakanat, E	1
Bai, P; Ding, Y; Luo, Y; Xiao, XM; Zhou, LY	1
Blee, K; Horner, PJ; Moi, H	1
Forbes, BA; Gerding, DN; Goldstein, EJ; Jacobus, NV; Jenkins, SG; Johnson, S; McDermott, LA; Mirrett, S; Patel, R; Snydman, DR; Stone, S; Thorpe, C	1
Hwang, JJ; Kim, N; Lee, DH; Park, YS; Shin, CM; Yoon, H	1
Ball, SL; Carrie, S	1
Choi, YJ; Kim, N; Kwon, YH; Lee, DH; Lee, JW; Lee, JY; Nam, RH; Suh, JH; Yoon, K	1
Freeman, J; Vernon, J; Vickers, R; Wilcox, MH	1
Cataldi, V; Cellini, L; Ciccaglione, AF; Di Bartolomeo, S; Di Campli, E; Di Giulio, M; Grossi, L; Marzio, L; Nostro, A	1
Bettoli, V; Join-Lambert, O; Nassif, A	1
von Hallern, B	1
Blee, K; Falk, L; Horner, PJ; Moi, H; van der Meijden, W	1
Casey, M; Igawa, G; Koike, R; Moriya, K; Nukui, Y; Okugawa, S; Saito, R; Sawabe, E; Tohda, S	1
Kriz, Z; Krutova, M; Kubicek, L; Kuijper, E; Matejkova, J; Nyc, O; Ruzicka, F; Tejkalova, R	1
Bago, J; Dominković, L; Gulić, S; Majstorović Barać, K; Marušić, M; Pezerović, D	1
Fattahi, G; Safarnejad, S; Shafahi Tilaki, S; Talebi Bezmin Abadi, A	1
Cheng, JW; Kong, F; Kudinha, T; Liao, JW; Xiao, M; Xu, YC; Yang, QW; Yu, SY; Zhou, ML	1
Choi, YJ; Kang, JB; Kim, N; Kwon, S; Lee, DH; Park, YS; Shin, CM; Yoon, H	1
Chen, YB; Fang, YH; Gu, SL; Li, LJ; Lv, T; Shen, P; Tang, LL	1
Morgando, A; Younes, R	1
Caminero Luna, JA; Cerezo Lajas, A; de Miguel Díez, J; Rodríguez Guzmán, MDC	1
Araj, GF; Becker, SL; Berger, FK; Bischoff, M; Dbaibo, G; Gärtner, B; Karaoui, WR; Mahfouz, R; Matar, GM; Rasheed, SS; Rimmani, HH; Sharara, AI; von Müller, L	1
Detry, O; Haumann, A; Meunier, P; Meurisse, M; Ongaro, S	1
Bernardy, J; Faldyna, M; Krejčí, J; Krutova, M; Matejkova, J; Nyc, O; Tkadlec, J; Zouharova, M	1
Akgul, O; Jean-Pierre, H; Justesen, US; Kulekci, G; Morris, T; Nagy, E; Soyletir, G; Ulger Toprak, N; Urban, E; Veloo, ACM; Wybo, I	1
Heo, JJ; Jung, K; Kim, JH; Kim, SE; Moon, W; Park, MI; Park, SJ; Roh, JH	1
Berger, F; Jazmati, N; Piepenbrock, E; Stelzer, Y	1
Cheng, JW; Fan, X; Hou, X; Kudinha, T; Liang, GW; Liu, C; Shao, DH; Su, JR; Wang, Y; Wei, M; Xiao, M; Xiong, ZJ; Xu, YC; Yang, CX; Yang, QW; Yu, SY	1
Ardila, CM; Bedoya-García, JA; Castañeda-Parra, LD; Flórez-Flórez, J; Guzmán, IC	1
Ikebuchi, K; Imai, K; Kawamura, T; Kodana, M; Maeda, T; Maesaki, S; Mitsutake, K; Murakami, T; Ogane, K; Onodera, A; Sakai, J; Takeuchi, S; Tarumoto, N	1
Ardila, CM; Bedoya-García, JA; Hernández-Casas, C	1
Berjeaud, JM; Crapart, S; Crépin, A; Ecale, F; El Houari, A; Laparre, J; Ramnath, M; Rodier, MH	1
Aarnio, M; Grönroos, J; Haijanen, J; Hurme, S; Ilves, I; Laukkarinen, J; Löyttyniemi, E; Marttila, H; Mattila, A; Meriläinen, S; Nordström, P; Paajanen, H; Pinta, T; Rantanen, T; Rautio, T; Rintala, J; Salminen, P; Sävelä, EL; Savolainen, H; Sippola, S; Sippola, T; Tammilehto, V	1
Jane, F; Jon J, V; Mark H, W	1
Adamczyk, M; Albrecht, V; Anderson, KF; Campbell, D; Elkins, CA; Gargis, AS; Guh, AY; Halpin, AL; Karlsson, M; Kent, AG; Korhonen, LC; Lutgring, JD; McAllister, G; McDonald, LC; McKay, SL; Paulick, AL; Rasheed, JK; Vlachos, N	1
Li, J; Li, N; Liu, B; Lü, X; Wang, H; Zhang, Y	1
Choi, SI; Jang, JY; Kim, N; Lee, DH; Lee, JW; Nam, RH; Song, CH	1
Chu, N; Gu, Y; Luo, H; Wang, Q; Xiao, Y; Yang, J; Zhang, J	1
Attin, T; Bensland, S; Eick, S; Karygianni, L; Kulik, EM; Thurnheer, T	1
Cheng, VC; Chow, KH; Fang, H; Ho, PL; Li, X; Tong, MK; Yan, MK	1

Reviews

5 review(s) available for moxifloxacin and metronidazole

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Moxifloxacin-based triple therapy versus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection: a meta-analysis of randomized controlled trials. Internal medicine (Tokyo, Japan), 2009, Volume: 48, Issue:24 Topics: Aza Compounds; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Moxifloxacin; Odds Ratio; Proton Pump Inhibitors; Quinolines; Randomized Controlled Trials as Topic; Treatment Outcome	2009
Second and third line treatment options for Helicobacter pylori eradication. World journal of gastroenterology, 2014, Feb-14, Volume: 20, Issue:6 Topics: Anti-Bacterial Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Moxifloxacin; Ofloxacin; Rifabutin; Rifamycins; Rifaximin; Salvage Therapy; Virulence Factors	2014
Management of non-gonococcal urethritis. BMC infectious diseases, 2015, Jul-29, Volume: 15 Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia trachomatis; Doxycycline; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Metronidazole; Moxifloxacin; Mycoplasma genitalium; Urethritis	2015
Antibiotic Treatment of Hidradenitis Suppurativa. Dermatologic clinics, 2016, Volume: 34, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Clindamycin; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Imipenem; Maintenance Chemotherapy; Metronidazole; Moxifloxacin; Remission Induction; Rifampin	2016

Trials

22 trial(s) available for moxifloxacin and metronidazole

Article	Year
Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapy. The Journal of emergency medicine, 2004, Volume: 27, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ceftriaxone; Community-Acquired Infections; Constipation; Drug Therapy, Combination; Emergency Medical Services; Female; Fluoroquinolones; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Nausea; Pneumonia, Bacterial; Prospective Studies; Quinolines; Safety; Time Factors; Treatment Outcome	2004
Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection. Helicobacter, 2006, Volume: 11, Issue:1 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Patient Compliance; Quinolines; Tetracycline; Treatment Outcome	2006
Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial. Sexually transmitted infections, 2006, Volume: 82, Issue:6 Topics: Administration, Oral; Adult; Anti-Infective Agents; Aza Compounds; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Metronidazole; Moxifloxacin; Ofloxacin; Pain; Pain Measurement; Pelvic Inflammatory Disease; Prospective Studies; Quinolines	2006
Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy. Helicobacter, 2007, Volume: 12, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Patient Compliance; Quinolines; Tetracycline	2007
One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin. Helicobacter, 2008, Volume: 13, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Aza Compounds; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Mixed Function Oxygenases; Moxifloxacin; Polymorphism, Restriction Fragment Length; Prospective Studies; Quinolines; Rifabutin	2008
Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial. Wiener klinische Wochenschrift, 2009, Volume: 121, Issue:1-2 Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Quinolines; Recurrence; Retreatment; Single-Blind Method; Tetracycline; Young Adult	2009
Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study). Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:2 Topics: Abdominal Abscess; Administration, Oral; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Appendicitis; Aza Compounds; Bacterial Infections; Ceftriaxone; Drug Therapy, Combination; Female; Fluoroquinolones; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Intestinal Perforation; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Peritonitis; Prospective Studies; Quinolines	2009
Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections. International journal of antimicrobial agents, 2009, Volume: 34, Issue:5 Topics: Adult; Anti-Bacterial Agents; Asia; Aza Compounds; Ceftriaxone; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Peritonitis; Quinolines; Treatment Outcome	2009
A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease. International journal of STD & AIDS, 2009, Volume: 20, Issue:10 Topics: Acute Disease; Adult; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Double-Blind Method; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Metronidazole; Moxifloxacin; Pelvic Inflammatory Disease; Quinolines; Treatment Outcome	2009
Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study. BJOG : an international journal of obstetrics and gynaecology, 2010, Volume: 117, Issue:12 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Levofloxacin; Metronidazole; Middle Aged; Moxifloxacin; Ofloxacin; Pelvic Inflammatory Disease; Quinolines; Treatment Outcome; Young Adult	2010
Single daily dose of moxifloxacin versus ofloxacin plus metronidazole as a new treatment approach to uncomplicated pelvic inflammatory disease: a multicentre prospective randomized trial. European journal of obstetrics, gynecology, and reproductive biology, 2013, Volume: 171, Issue:1 Topics: Adolescent; Adult; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Metronidazole; Moxifloxacin; Ofloxacin; Patient Compliance; Pelvic Inflammatory Disease; Quinolines	2013
Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy. BMC gastroenterology, 2013, Sep-19, Volume: 13 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Disease-Free Survival; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Peptic Ulcer; Quinolines; Recurrence; Stomach Neoplasms; Tetracycline; Treatment Outcome	2013
Clinical efficacy and safety of moxifloxacin versus levofloxacin plus metronidazole for community-acquired pneumonia with aspiration factors. Chinese medical journal, 2014, Volume: 127, Issue:7 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Moxifloxacin; Pneumonia; Prospective Studies	2014
Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates. Journal of digestive diseases, 2014, Volume: 15, Issue:9 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Metronidazole; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Treatment Outcome; Young Adult	2014
Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease. World journal of gastroenterology, 2015, Apr-28, Volume: 21, Issue:16 Topics: Aged; Anti-Bacterial Agents; Biopsy; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medication Adherence; Metronidazole; Middle Aged; Moxifloxacin; Multivariate Analysis; Odds Ratio; Pilot Projects; Predictive Value of Tests; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Republic of Korea; Stomach Diseases; Time Factors; Treatment Outcome	2015
Systemic moxifloxacin vs amoxicillin/metronidazole adjunct to non-surgical treatment in generalized aggressive periodontitis. Medicina oral, patologia oral y cirugia bucal, 2015, Jul-01, Volume: 20, Issue:4 Topics: Adult; Aggressive Periodontitis; Amoxicillin; Anti-Infective Agents; Drug Therapy, Combination; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Metronidazole; Moxifloxacin; Young Adult	2015
Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication. World journal of gastroenterology, 2015, Sep-21, Volume: 21, Issue:35 Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medication Adherence; Metronidazole; Middle Aged; Moxifloxacin; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Republic of Korea; Time Factors; Treatment Outcome	2015
Comparison of the efficacy of culture-based tailored therapy for Helicobacter pylori eradication with that of the traditional second-line rescue therapy in Korean patients: a prospective single tertiary center study. Scandinavian journal of gastroenterology, 2016, Volume: 51, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Republic of Korea; Tertiary Care Centers; Tetracycline; Young Adult	2016
Moxifloxacin versus amoxicillin plus metronidazole as adjunctive therapy for generalized aggressive periodontitis: a pilot randomized controlled clinical trial. Quintessence international (Berlin, Germany : 1985), 2020, Volume: 51, Issue:8 Topics: Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Dental Scaling; Humans; Metronidazole; Moxifloxacin; Periodontal Attachment Loss; Periodontal Pocket; Porphyromonas gingivalis; Treatment Outcome	2020
Effects on clinical outcomes of adjunctive moxifloxacin versus amoxicillin plus metronidazole in periodontitis patients harboring Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythia: exploratory analyses from a clinic Quintessence international (Berlin, Germany : 1985), 2021, Volume: 52, Issue:1 Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Humans; Metronidazole; Moxifloxacin; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis; Porphyromonas gingivalis; Tannerella; Tannerella forsythia	2021
Effect of Oral Moxifloxacin vs Intravenous Ertapenem Plus Oral Levofloxacin for Treatment of Uncomplicated Acute Appendicitis: The APPAC II Randomized Clinical Trial. JAMA, 2021, 01-26, Volume: 325, Issue:4 Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Adult; Anti-Bacterial Agents; Appendectomy; Appendicitis; Drug Therapy, Combination; Ertapenem; Female; Follow-Up Studies; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Moxifloxacin; Tomography, X-Ray Computed; Young Adult	2021
Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea. Helicobacter, 2023, Volume: 28, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Prevalence; Republic of Korea; Tertiary Care Centers	2023

Other Studies

78 other study(ies) available for moxifloxacin and metronidazole

Article	Year
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen	2007
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles	2007
Antimicrobial susceptibilities of Peptostreptococcus anaerobius and the newly described Peptostreptococcus stomatis isolated from various human sources. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteremia; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Peptostreptococcus; Species Specificity	2007
In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Microbial Sensitivity Tests; United States	2007
Antimicrobial susceptibilities and clinical sources of Dialister species. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae	2007
Evaluation of a 2-pyridone, KRQ-10018, against Mycobacterium tuberculosis in vitro and in vivo. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Animals; Antitubercular Agents; Biological Availability; Interferon-gamma; Mice; Mice, Inbred C57BL; Mice, Knockout; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyridones; Quinolones; Treatment Outcome; Tuberculosis, Pulmonary	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Spain; Species Specificity; Time Factors	2008
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Blood; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Taiwan	2008
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Glycosides; Humans; In Vitro Techniques; Microbial Sensitivity Tests	2008
In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Bacteroides fragilis; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Positive Cocci; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Republic of Korea	2010
MICE models: superior to the HERG model in predicting Torsade de Pointes. Scientific reports, 2013, Volume: 3 Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes	2013
Antitubercular Nitroimidazoles Revisited: Synthesis and Activity of the Authentic 3-Nitro Isomer of Pretomanid. ACS medicinal chemistry letters, 2017, Dec-14, Volume: 8, Issue:12 Topics:	2017
Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:3 Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Cefoxitin; Cephamycins; Clindamycin; Fluoroquinolones; Imipenem; Metronidazole; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Thienamycins	1998
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:1 Topics: Acetamides; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fluoroquinolones; Fusidic Acid; Gatifloxacin; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Quinolines; Sensitivity and Specificity; Vancomycin	2002
Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams. International journal of antimicrobial agents, 2002, Volume: 20, Issue:5 Topics: Anaerobiosis; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; beta-Lactams; Ciprofloxacin; Clindamycin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines	2002
In vitro antimicrobial susceptibility of Brachyspira pilosicoli isolates from humans. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Ceftriaxone; Chloramphenicol; Drug Resistance, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Meropenem; Metronidazole; Moxifloxacin; Quinolines; Spirochaetales; Swine; Tetracycline; Thienamycins	2003
Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - an in vitro study. Journal of clinical periodontology, 2004, Volume: 31, Issue:5 Topics: Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Biofilms; Clindamycin; Doxycycline; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Moxifloxacin; Porphyromonas gingivalis; Quinolines; Saliva, Artificial; Streptococcus constellatus; Time Factors	2004
Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice. Chemotherapy, 2004, Volume: 50, Issue:2 Topics: Abdominal Abscess; Animals; Anti-Bacterial Agents; Aza Compounds; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Disease Models, Animal; Fluoroquinolones; Injections, Subcutaneous; Levofloxacin; Male; Metronidazole; Mice; Moxifloxacin; Ofloxacin; Quinolines	2004
Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: an in vitro study. Journal of periodontology, 2004, Volume: 75, Issue:10 Topics: Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Clindamycin; Colony Count, Microbial; Doxycycline; Fluoroquinolones; Humans; Intracellular Space; KB Cells; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Periodontitis; Periodontium; Porphyromonas gingivalis; Quinolines; Streptococcus constellatus; Time Factors	2004
Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:2 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteroides fragilis; Bacteroides Infections; Chromatography, High Pressure Liquid; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Half-Life; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Ofloxacin; Quinolines	2005
Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:5 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Fluoroquinolones; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quinolines	2005
In vitro activity of amoxicillin, clindamycin, doxycycline, metronidazole, and moxifloxacin against oral Actinomyces. Journal of endodontics, 2007, Volume: 33, Issue:5 Topics: Actinomyces; Actinomycosis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Clindamycin; Doxycycline; Fluoroquinolones; Humans; Metronidazole; Moxifloxacin; Periapical Periodontitis; Quinolines	2007
Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials. Oral microbiology and immunology, 2007, Volume: 22, Issue:5 Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Blood; Clindamycin; Culture Media; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Anaerobic Bacteria; Hemin; Humans; Ketolides; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Penicillin Resistance; Periodontitis; Quinolines; Saliva; Vitamin K	2007
A comparison of treatment outcomes for moxifloxacin versus ofloxacin/metronidazole for first-line treatment of uncomplicated non-gonococcal pelvic inflammatory disease. International journal of STD & AIDS, 2010, Volume: 21, Issue:3 Topics: Adolescent; Adult; Anti-Infective Agents; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Metronidazole; Middle Aged; Moxifloxacin; Ofloxacin; Pelvic Inflammatory Disease; Quinolines; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome	2010
Activity of drug combinations against dormant Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: 3T3 Cells; Adipocytes; Amikacin; Animals; Antitubercular Agents; Aza Compounds; Capreomycin; Colony Count, Microbial; Drug Combinations; Drug Resistance, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Latent Tuberculosis; Metronidazole; Mice; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Rifampin	2010
Antibiotic resistance of subgingival species in chronic periodontitis patients. Journal of periodontal research, 2010, Volume: 45, Issue:4 Topics: Adult; Aged; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Infective Agents; Aza Compounds; Bacteriological Techniques; beta-Lactam Resistance; Chronic Periodontitis; Clindamycin; Colombia; Dental Plaque; Drug Resistance, Bacterial; Female; Fluoroquinolones; Fusobacterium nucleatum; Gingival Hemorrhage; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Periodontal Attachment Loss; Periodontal Pocket; Porphyromonas gingivalis; Prevotella; Quinolines	2010
[Prevalence of Clostridium difficile in the gastrointestinal tract of hospitalized children under two years of age]. Medycyna doswiadczalna i mikrobiologia, 2010, Volume: 62, Issue:1 Topics: Aza Compounds; Ciprofloxacin; Clindamycin; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Female; Fluoroquinolones; Gastrointestinal Tract; Gatifloxacin; Genotype; Humans; Infant; Infant, Newborn; Male; Metronidazole; Moxifloxacin; Phenotype; Quinolines; Species Specificity; Vancomycin	2010
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:11 Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Sequence Analysis, Protein; Taiwan; Tetracyclines; Tigecycline	2010
Response of Gardnerella vaginalis biofilm to 5 days of moxifloxacin treatment. FEMS immunology and medical microbiology, 2011, Volume: 61, Issue:1 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Biofilms; Female; Fluoroquinolones; Gardnerella vaginalis; Humans; Metronidazole; Middle Aged; Moxifloxacin; Quinolines; Time Factors; Treatment Outcome; Urine; Vagina; Vaginosis, Bacterial; Young Adult	2011
In vitro activity of ceftaroline against a broad spectrum of recent clinical anaerobic isolates. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Anaerobic; Ceftaroline; Ceftriaxone; Cephalosporins; Clindamycin; Fluoroquinolones; Imipenem; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Quinolines; Tigecycline	2011
Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa. Dermatology (Basel, Switzerland), 2011, Volume: 222, Issue:1 Topics: Adult; Anti-Infective Agents; Antibiotics, Antitubercular; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Metronidazole; Middle Aged; Moxifloxacin; Prognosis; Quinolines; Recurrence; Remission Induction; Retrospective Studies; Rifampin; Treatment Outcome; Young Adult	2011
Antimicrobial susceptibilities and molecular epidemiology of clinical isolates of Clostridium difficile in taiwan. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4 Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Clostridioides difficile; Fluoroquinolones; Genotype; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Moxifloxacin; Polymerase Chain Reaction; Quinolines; Ribotyping; Taiwan; Vancomycin	2011
Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model. Journal of periodontology, 2011, Volume: 82, Issue:9 Topics: Acetamides; Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Capnocytophaga; Coculture Techniques; Coinfection; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Metronidazole; Microbial Interactions; Minocycline; Moxifloxacin; Oxazolidinones; Penicillin G; Peptostreptococcus; Peri-Implantitis; Periodontitis; Quinolines; Sulbactam	2011
[Regional difference of antibiotic resistance of helicobacter pylori strains in Korea]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2011, Volume: 57, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Republic of Korea; Tetracycline	2011
Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates. The new microbiologica, 2012, Volume: 35, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Algorithms; Aza Compounds; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Bacterial; Enterotoxins; Feces; Female; Fluoroquinolones; Genes, Bacterial; Glutamate Dehydrogenase; Humans; Immunoenzyme Techniques; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Prevalence; Quinolines; Ribotyping; Sensitivity and Specificity; Young Adult	2012
LC-MS/MS method for the simultaneous determination of PA-824, moxifloxacin and pyrazinamide in rat plasma and its application to pharmacokinetic study. Journal of pharmaceutical and biomedical analysis, 2014, Volume: 97 Topics: Animals; Chromatography, Liquid; Drug Interactions; Fluoroquinolones; Limit of Detection; Metronidazole; Moxifloxacin; Nitroimidazoles; Plasma; Pyrazinamide; Rats; Tandem Mass Spectrometry	2014
Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection. Gut and liver, 2015, Volume: 9, Issue:4 Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Retrospective Studies; Tetracycline; Treatment Outcome	2015
Characterization of Clostridium difficile isolates from human fecal samples and retail meat from Pennsylvania. Foodborne pathogens and disease, 2014, Volume: 11, Issue:10 Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cattle; Chickens; Clindamycin; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Feces; Fluoroquinolones; Gene Deletion; Genes, Bacterial; Genotype; Humans; Meat; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Pennsylvania; Phenotype; Repressor Proteins; Ribotyping; Swine; Vancomycin	2014
The efficacy of moxifloxacin-containing triple therapy after standard triple, sequential, or concomitant therapy failure for Helicobacter pylori eradication in Korea. Gut and liver, 2014, Volume: 8, Issue:6 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Cohort Studies; Drug Therapy, Combination; Female; Fluoroquinolones; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Peptic Ulcer; Rabeprazole; Republic of Korea; Retrospective Studies; Salvage Therapy; Stomach; Tetracycline; Treatment Failure; Treatment Outcome; Urea	2014
Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia. Anaerobe, 2015, Volume: 34 Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Fluoroquinolones; Genetic Variation; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Vancomycin; Victoria	2015
2015 UK National Guideline on the management of non-gonococcal urethritis. International journal of STD & AIDS, 2016, Volume: 27, Issue:2 Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Disease Management; Doxycycline; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Male; Metronidazole; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Practice Guidelines as Topic; United Kingdom; Urethritis	2016
Susceptibility of Helicobacter pylori to antibiotics in Chinese patients. Journal of digestive diseases, 2015, Volume: 16, Issue:8 Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Minocycline; Moxifloxacin; Peptic Ulcer; Risk Factors; Young Adult	2015
U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridioides difficile; Diarrhea; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fidaxomicin; Fluoroquinolones; Genes, Bacterial; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multiplex Polymerase Chain Reaction; Prohibitins; Sentinel Surveillance; United States; Vancomycin	2015
Pott's puffy tumour: a forgotten diagnosis. BMJ case reports, 2015, Sep-29, Volume: 2015 Topics: Anti-Infective Agents; Fluoroquinolones; Frontal Bone; Frontal Sinusitis; Humans; Magnetic Resonance Imaging; Male; Metronidazole; Moxifloxacin; Pott Puffy Tumor; Tomography, X-Ray Computed	2015
Susceptibility of Clostridium difficile Isolates of Varying Antimicrobial Resistance Phenotypes to SMT19969 and 11 Comparators. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Benzimidazoles; Ceftriaxone; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Fidaxomicin; Fluoroquinolones; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Phenotype; Pyridines; Ribotyping; Vancomycin	2016
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy. Scandinavian journal of gastroenterology, 2016, Volume: 51, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Child; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Fluoroquinolones; Gastric Fundus; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pyloric Antrum; Rifabutin; Tetracycline; Young Adult	2016
Case 7: highly infected post-surgical wound. Journal of wound care, 2016, Volume: 25, Issue:3 Suppl Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Cefuroxime; Diabetes Mellitus, Type 2; Exudates and Transudates; Fluoroquinolones; Humans; Imines; Male; Metronidazole; Moxifloxacin; Pyridines; Surgical Wound Infection; Therapeutic Irrigation	2016
2016 European guideline on the management of non-gonococcal urethritis. International journal of STD & AIDS, 2016, Volume: 27, Issue:11 Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia trachomatis; Doxycycline; Drug Resistance, Bacterial; Fluoroquinolones; Guidelines as Topic; Humans; Metronidazole; Moxifloxacin; Mycoplasma genitalium; Urethritis	2016
Comparison of agar dilution and broth microdilution methods for Clostridium difficile antimicrobial susceptibility testing. Journal of global antimicrobial resistance, 2016, Volume: 7 Topics: Agar; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Fluoroquinolones; Japan; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Vancomycin	2016
Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis. Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:5 Topics: Aged; Amino Acid Substitution; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Clostridioides difficile; Clostridium Infections; Czech Republic; DNA Gyrase; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Capillary; Female; Fluoroquinolones; Gene Expression; Humans; Male; Methyltransferases; Metronidazole; Microbial Sensitivity Tests; Minisatellite Repeats; Moxifloxacin; Multilocus Sequence Typing; Retrospective Studies; Ribotyping; Tertiary Care Centers; Vancomycin	2017
Bismuth-based quadruple therapy modified with moxifloxacin for Helicobacter pylori eradication. Minerva gastroenterologica e dietologica, 2017, Volume: 63, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Drug Therapy, Combination; Female; Fluoroquinolones; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Pantoprazole; Patient Compliance; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome	2017
Moxifloxacin, but not Metronidazole can be used in therapeutic regimens against Helicobacter pylori. Minerva gastroenterologica e dietologica, 2017, Volume: 63, Issue:2 Topics: Amoxicillin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Moxifloxacin	2017
High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2018, Volume: 51, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; China; Clostridioides difficile; Clostridium Infections; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Fidaxomicin; Fluoroquinolones; Genes, Bacterial; Hospitals, Teaching; Hospitals, University; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Multilocus Sequence Typing; Ribotyping; Tigecycline; Vancomycin	2018
[The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure in The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2017, Aug-25, Volume: 70, Issue:2 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Topoisomerase II Inhibitors; Treatment Failure; Treatment Outcome	2017
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4-year period in China. Journal of medical microbiology, 2018, Volume: 67, Issue:1 Topics: Anti-Infective Agents; Bacterial Proteins; China; Clindamycin; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Moxifloxacin; Tertiary Care Centers; Vancomycin	2018
Comment on Helicobacter pylori eradication using metronidazole. Minerva gastroenterologica e dietologica, 2018, Volume: 64, Issue:1 Topics: Amoxicillin; Bismuth; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Moxifloxacin	2018
Antituberculosis Treatment in a Patient with Celiac Disease. Archivos de bronconeumologia, 2018, Volume: 54, Issue:6 Topics: Aged; Antitubercular Agents; Celiac Disease; Diarrhea; Diet, Gluten-Free; Drug Compounding; Drug Substitution; Drug Therapy, Combination; Ethambutol; Glutens; Hemoptysis; Humans; Isoniazid; Male; Metronidazole; Moxifloxacin; Pyrazinamide; Rifampin; Smoking; Tomography, X-Ray Computed; Tuberculosis, Pulmonary	2018
Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon. International journal of medical microbiology : IJMM, 2018, Volume: 308, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Fluoroquinolones; Humans; Lebanon; Male; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Phenotype; Ribotyping; Vancomycin	2018
Acute pelvic inflammatory disease as a rare cause of acute small bowel obstruction. Acta chirurgica Belgica, 2019, Volume: 119, Issue:5 Topics: Abdomen, Acute; Acute Disease; Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Female; Humans; Intestinal Obstruction; Intestine, Small; Laparoscopy; Metronidazole; Moxifloxacin; Pelvic Inflammatory Disease; Tomography, X-Ray Computed	2019
The emergence of Clostridium difficile PCR ribotype 078 in piglets in the Czech Republic clusters with Clostridium difficile PCR ribotype 078 isolates from Germany, Japan and Taiwan. International journal of medical microbiology : IJMM, 2018, Volume: 308, Issue:7 Topics: Amino Acid Substitution; Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Czech Republic; DNA Gyrase; Germany; Japan; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Ribotyping; Swine; Taiwan; Tetracycline; Vancomycin	2018
A multicenter survey of antimicrobial susceptibility of Prevotella species as determined by Etest methodology. Anaerobe, 2018, Volume: 52 Topics: Ampicillin; Anti-Bacterial Agents; Bacteroidaceae Infections; Clindamycin; Disk Diffusion Antimicrobial Tests; Fluoroquinolones; Humans; Kuwait; Meropenem; Metronidazole; Moxifloxacin; Prevotella; Sulbactam; Thienamycins; Turkey	2018
Effect of 7-day Bismuth Quadruple Therapy versus 14-day Moxifloxacin Triple Therapy for Second-line The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2019, Jan-25, Volume: 73, Issue:1 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome	2019
Changes in Clostridium (Clostridioides) difficile PCR-Ribotype Distribution and Antimicrobial Resistance in a German Tertiary Care Hospital Over the Last 10 Years. Current microbiology, 2019, Volume: 76, Issue:4 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Epidemiological Monitoring; Feces; Germany; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ribotyping; Tertiary Care Centers; Vancomycin	2019
The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China. International journal of antimicrobial agents, 2020, Volume: 56, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; China; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; DNA Gyrase; Drug Resistance, Bacterial; Enterotoxins; Fluoroquinolones; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Moxifloxacin; Vancomycin	2020
Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan. Anaerobe, 2020, Volume: 64 Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Blood Culture; DNA Transposable Elements; Doripenem; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Imipenem; Japan; Meropenem; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Piperacillin, Tazobactam Drug Combination; Prevalence; Sulbactam; Tertiary Care Centers	2020
In vitro sensitivity of 30 anaerobic bacterial strains of the human intestinal core microbiota to antibiotics: Culture and LC-MS/MS approaches. Anaerobe, 2021, Volume: 67 Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, Liquid; Gastrointestinal Microbiome; Humans; Mass Screening; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Sulfamethoxazole; Tandem Mass Spectrometry	2021
Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities. Anaerobe, 2021, Volume: 70 Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; United Kingdom; Vancomycin	2021
Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 03-04, Volume: 76, Issue:5 Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Genomics; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ribotyping; United States; Vancomycin	2023
Antibiotic susceptibility and biofilm-forming ability of Veillonella strains. Anaerobe, 2022, Volume: 78 Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Cefoxitin; Clindamycin; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Piperacillin; Tazobactam; Tetracyclines; Vancomycin; Veillonella	2022
Antimicrobial Resistance of Helicobacter Pylori Among Low-resource Chinese Minorities. Alternative therapies in health and medicine, 2023, Volume: 29, Issue:2 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; China; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; East Asian People; Female; Gentamicins; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Moxifloxacin; Rifampin	2023
Antibiotic Resistance among Fusobacterium, Capnocytophaga, and Leptotrichia Species of the Oral Cavity. Oral health & preventive dentistry, 2023, Mar-15, Volume: 21, Issue:1 Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Capnocytophaga; Ciprofloxacin; Clindamycin; Doxycycline; Drug Resistance, Bacterial; Fusobacterium; Humans; Leptothrix; Leptotrichia; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Periodontal Diseases	2023
Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong, 2020-2021. Anaerobe, 2023, Volume: 82 Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Clindamycin; Hong Kong; Imipenem; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Retrospective Studies; RNA, Ribosomal, 16S	2023